Lately, some biomarkers of neurodegenerative disease including neurofilament light 9, tau 10, and amyloid 11; and genetic risk for AD 12 in cognitively normal samples were found to associate with MBI. The gene discussed is MAPT; the disease is Alzheimer disease.